ADHD drug monographs will now include statements about the potential risk for sudden cardiac death

ADHD drug monographs will now include statements about the potential risk for sudden cardiac death.

Health Canada is asking manufacturers of Strattera, Adderall XR, methylphenidate, and the other ADHD drugs to include new warnings.

There are over 20 reports of sudden death in children and adults taking ADHD stimulants. Surprisingly, some of these deaths occurred in patients without any apparent cardiac abnormalities.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote